Drug intelligence / Profile preview

Brite Eye Drops

Development stage
Unknown
Lead developer
Pharmtak
Modality
Small Molecules
Administration
Ophthalmic, Oral
01

Overview

Brite Eye Drops is a multi-ingredient ophthalmic solution developed and marketed by Pharmtak. It is primarily indicated for the symptomatic relief of eye redness, congestion, and minor irritation caused by environmental factors such as dust, smoke, or eye strain. The formulation typically contains a combination of sympathomimetic amines, including naphazoline hydrochloride and phenylephrine hydrochloride, which act as vasoconstrictors by stimulating alpha-adrenergic receptors in the conjunctival blood vessels. This action reduces swelling and redness. Additionally, the formulation incorporates cooling agents such as camphor and menthol, which serve as mild counter-irritants to provide a soothing sensation and immediate relief from ocular discomfort. Pharmtak also markets a tablet version under the same brand name, which is formulated as a nutritional supplement containing antioxidants like lutein and zeaxanthin to support overall eye health.

Brand names
Brite Eye Drops
Other names
Brite Tablets
02

Targets

ADRA1A (α1A)ADRA2A (α2A)TRPV1 (Transient receptor potential cation channel subfamily V member 1)TRPM8 (Transient receptor potential cation channel subfamily M member 8)

Beyond the preview

Go deeper on Brite Eye Drops.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Brite Eye Drops.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call